Connecting for innovation and equity in global health
- This event has passed.
Beyond the Initial Cure: Expanding the Horizons of Orphan Drug Indications
March 27 @ 9:00 am - 10:00 am
Join Stanford University Byers Center for Biodesign for their webinar, Beyond the Initial Cure: Expanding the Horizons of Orphan Drug Indications. The Inflation Reduction Act stands as key legislation aimed at improving the accessibility of medicines. Yet, it has introduced some unintended consequences for biotechnology innovation and patients suffering from orphan diseases. In response, the Orphan Cures Act has emerged as a proposed bill dedicated to bolstering research and development for rare diseases. This webinar will explore how these legislative efforts intersect, examining their impact on the delicate balance between innovation, affordability, and access in the realm of rare disease treatments.